APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Chinese Patent Medicine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Chinese Patent Medicine Industry Growth and Trends Forecast to 2032

Report ID 173977390120 December 2025115 pages

Choose your research edition.

Industry ResearchChinese Patent Medicine Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Chinese Patent Medicine Industry Growth and Trends Forecast to 2032115 pages · $3,450 USDMarket StructureGlobal Chinese Patent Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Chinese Patent Medicine Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Chinese Patent Medicine Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Chinese Patent Medicine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Chinese Patent Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Chinese Patent Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Chinese Patent Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Chinese Patent Medicine include Chongqing Pharmaceutical Co., Ltd, China Pharmaceutical Group Corporation, Xinhualu Anti-Pharmaceutical Group Co., Ltd., Tianjin Pharmaceutical Group Co., Ltd., Taiji Group Co., Ltd., Shijiazhuang Pharmaceutical Group Co., Ltd., Shanghai Pharmaceutical (Group) Co., Ltd., Nanjing Pharmaceutical Co., Ltd and Nanjing Pharmaceutical Industry (Group) Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Chinese Patent Medicine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Chinese Patent Medicine market size, estimates, and forecasts are presented in terms of sales volume (k tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Chinese Patent Medicine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Chinese Patent Medicine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Chinese Patent Medicine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Chinese Patent Medicine Market by Company

Chongqing Pharmaceutical Co., Ltd

China Pharmaceutical Group Corporation

Xinhualu Anti-Pharmaceutical Group Co., Ltd.

Tianjin Pharmaceutical Group Co., Ltd.

Taiji Group Co., Ltd.

Shijiazhuang Pharmaceutical Group Co., Ltd.

Shanghai Pharmaceutical (Group) Co., Ltd.

Nanjing Pharmaceutical Co., Ltd

Nanjing Pharmaceutical Industry (Group) Co., Ltd.

Jiangxi Pharmaceutical Group Corporation

Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd.

North China Pharmaceutical Group Co., Ltd.

Hangzhou Huadong Pharmaceutical Group Co., Ltd.

Harbin Pharmaceutical Group Co., Ltd

Guangzhou Pharmaceutical Group Co., Ltd.

Northeast Pharmaceutical Group Co., Ltd.

Chinese Patent Medicine Segment by Type

Liquid

Tablet

Syrup

Others

Chinese Patent Medicine Segment by Application

Online Sales

Offline Sales

Chinese Patent Medicine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chinese Patent Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chinese Patent Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chinese Patent Medicine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Chinese Patent Medicine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Chinese Patent Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Liquid Table 2. Major Company of Tablet Table 3. Major Company of Syrup Table 4. Major Company of Others Table 5. Global Chinese Patent Medicine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Chinese Patent Medicine Sales by Type (2021-2026) & (k tons) Table 7. Global Chinese Patent Medicine Sales Market Share in Volume by Type (2021-2026) Table 8. Global Chinese Patent Medicine Sales by Type (2021-2026) & (US$ Million) Table 9. Global Chinese Patent Medicine Sales Market Share in Value by Type (2021-2026) Table 10. Global Chinese Patent Medicine Price by Type (2021-2026) & (US$/ton) Table 11. Global Chinese Patent Medicine Sales by Type (2027-2032) & (k tons) Table 12. Global Chinese Patent Medicine Sales Market Share in Volume by Type (2027-2032) Table 13. Global Chinese Patent Medicine Sales by Type (2027-2032) & (US$ Million) Table 14. Global Chinese Patent Medicine Sales Market Share in Value by Type (2027-2032) Table 15. Global Chinese Patent Medicine Price by Type (2027-2032) & (US$/ton) Table 16. North America Chinese Patent Medicine Sales by Type (2021-2026) & (k tons) Table 17. North America Chinese Patent Medicine Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Chinese Patent Medicine Sales by Type (2021-2026) & (k tons) Table 19. Europe Chinese Patent Medicine Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Chinese Patent Medicine Sales by Type (2021-2026) & (k tons) Table 21. Asia-Pacific Chinese Patent Medicine Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Chinese Patent Medicine Sales by Type (2021-2026) & (k tons) Table 23. Latin America Chinese Patent Medicine Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Chinese Patent Medicine Sales by Type (2021-2026) & (k tons) Table 25. Middle East and Africa Chinese Patent Medicine Sales by Type (2021-2026) & (US$ Million) Table 26. Chinese Patent Medicine Industry Trends Table 27. Chinese Patent Medicine Industry Drivers Table 28. Chinese Patent Medicine Industry Opportunities and Challenges Table 29. Chinese Patent Medicine Industry Restraints Table 30. Global Chinese Patent Medicine Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Chinese Patent Medicine Revenue Market Share by Company (2021-2026) Table 32. Global Chinese Patent Medicine Sales by Company (2021-2026) & (k tons) Table 33. Global Chinese Patent Medicine Sales Share by Company (2021-2026) Table 34. Global Chinese Patent Medicine Market Price by Company (2021-2026) & (US$/ton) Table 35. Global Chinese Patent Medicine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Chinese Patent Medicine Major Company Production Sites and Headquarters Table 37. Global Chinese Patent Medicine Company, Product Type & Application Table 38. Global Chinese Patent Medicine Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Chinese Patent Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Chinese Patent Medicine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Chinese Patent Medicine Sales by Region (2021-2026) & (k tons) Table 43. Global Chinese Patent Medicine Sales Market Share in Volume by Region (2021-2026) Table 44. Global Chinese Patent Medicine Sales by Region (2021-2026) & (US$ Million) Table 45. Global Chinese Patent Medicine Sales Market Share in Value by Region (2021-2026) Table 46. Global Chinese Patent Medicine Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 47. Global Chinese Patent Medicine Sales by Region (2027-2032) & (k tons) Table 48. Global Chinese Patent Medicine Sales Market Share in Volume by Region (2027-2032) Table 49. Global Chinese Patent Medicine Sales by Region (2027-2032) & (US$ Million) Table 50. Global Chinese Patent Medicine Sales Market Share in Value by Region (2027-2032) Table 51. Global Chinese Patent Medicine Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2027-2032) Table 52. Global Chinese Patent Medicine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Chinese Patent Medicine Sales by Application (2021-2026) & (k tons) Table 54. Global Chinese Patent Medicine Sales Market Share in Volume by Application (2021-2026) Table 55. Global Chinese Patent Medicine Sales by Application (2021-2026) & (US$ Million) Table 56. Global Chinese Patent Medicine Sales Market Share in Value by Application (2021-2026) Table 57. Global Chinese Patent Medicine Price by Application (2021-2026) & (US$/ton) Table 58. Global Chinese Patent Medicine Sales by Application (2027-2032) & (k tons) Table 59. Global Chinese Patent Medicine Sales Market Share in Volume by Application (2027-2032) Table 60. Global Chinese Patent Medicine Sales by Application (2027-2032) & (US$ Million) Table 61. Global Chinese Patent Medicine Sales Market Share in Value by Application (2027-2032) Table 62. Global Chinese Patent Medicine Price by Application (2027-2032) & (US$/ton) Table 63. North America Chinese Patent Medicine Sales by Application (2021-2026) & (k tons) Table 64. North America Chinese Patent Medicine Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Chinese Patent Medicine Sales by Application (2021-2026) & (k tons) Table 66. Europe Chinese Patent Medicine Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Chinese Patent Medicine Sales by Application (2021-2026) & (k tons) Table 68. Asia-Pacific Chinese Patent Medicine Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Chinese Patent Medicine Sales by Application (2021-2026) & (k tons) Table 70. Latin America Chinese Patent Medicine Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Chinese Patent Medicine Sales by Application (2021-2026) & (k tons) Table 72. Middle East and Africa Chinese Patent Medicine Sales by Application (2021-2026) & (US$ Million) Table 73. Chongqing Pharmaceutical Co., Ltd Company Information Table 74. Chongqing Pharmaceutical Co., Ltd Business Overview Table 75. Chongqing Pharmaceutical Co., Ltd Chinese Patent Medicine Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 76. Chongqing Pharmaceutical Co., Ltd Chinese Patent Medicine Product Portfolio Table 77. Chongqing Pharmaceutical Co., Ltd Recent Development Table 78. China Pharmaceutical Group Corporation Company Information Table 79. China Pharmaceutical Group Corporation Business Overview Table 80. China Pharmaceutical Group Corporation Chinese Patent Medicine Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 81. China Pharmaceutical Group Corporation Chinese Patent Medicine Product Portfolio Table 82. China Pharmaceutical Group Corporation Recent Development Table 83. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Company Information Table 84. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Business Overview Table 85. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 86. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio Table 87. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Recent Development Table 88. Tianjin Pharmaceutical Group Co., Ltd. Company Information Table 89. Tianjin Pharmaceutical Group Co., Ltd. Business Overview Table 90. Tianjin Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 91. Tianjin Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio Table 92. Tianjin Pharmaceutical Group Co., Ltd. Recent Development Table 93. Taiji Group Co., Ltd. Company Information Table 94. Taiji Group Co., Ltd. Business Overview Table 95. Taiji Group Co., Ltd. Chinese Patent Medicine Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 96. Taiji Group Co., Ltd. Chinese Patent Medicine Product Portfolio Table 97. Taiji Group Co., Ltd. Recent Development Table 98. Shijiazhuang Pharmaceutical Group Co., Ltd. Company Information Table 99. Shijiazhuang Pharmaceutical Group Co., Ltd. Business Overview Table 100. Shijiazhuang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 101. Shijiazhuang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio Table 102. Shijiazhuang Pharmaceutical Group Co., Ltd. Recent Development Table 103. Shanghai Pharmaceutical (Group) Co., Ltd. Company Information Table 104. Shanghai Pharmaceutical (Group) Co., Ltd. Business Overview Table 105. Shanghai Pharmaceutical (Group) Co., Ltd. Chinese Patent Medicine Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 106. Shanghai Pharmaceutical (Group) Co., Ltd. Chinese Patent Medicine Product Portfolio Table 107. Shanghai Pharmaceutical (Group) Co., Ltd. Recent Development Table 108. Nanjing Pharmaceutical Co., Ltd Company Information Table 109. Nanjing Pharmaceutical Co., Ltd Business Overview Table 110. Nanjing Pharmaceutical Co., Ltd Chinese Patent Medicine Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 111. Nanjing Pharmaceutical Co., Ltd Chinese Patent Medicine Product Portfolio Table 112. Nanjing Pharmaceutical Co., Ltd Recent Development Table 113. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Company Information Table 114. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Business Overview Table 115. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Chinese Patent Medicine Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 116. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Chinese Patent Medicine Product Portfolio Table 117. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Recent Development Table 118. Jiangxi Pharmaceutical Group Corporation Company Information Table 119. Jiangxi Pharmaceutical Group Corporation Business Overview Table 120. Jiangxi Pharmaceutical Group Corporation Chinese Patent Medicine Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 121. Jiangxi Pharmaceutical Group Corporation Chinese Patent Medicine Product Portfolio Table 122. Jiangxi Pharmaceutical Group Corporation Recent Development Table 123. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Company Information Table 124. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Business Overview Table 125. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 126. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio Table 127. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Recent Development Table 128. North China Pharmaceutical Group Co., Ltd. Company Information Table 129. North China Pharmaceutical Group Co., Ltd. Business Overview Table 130. North China Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 131. North China Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio Table 132. North China Pharmaceutical Group Co., Ltd. Recent Development Table 133. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Company Information Table 134. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Business Overview Table 135. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 136. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio Table 137. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Recent Development Table 138. Harbin Pharmaceutical Group Co., Ltd Company Information Table 139. Harbin Pharmaceutical Group Co., Ltd Business Overview Table 140. Harbin Pharmaceutical Group Co., Ltd Chinese Patent Medicine Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 141. Harbin Pharmaceutical Group Co., Ltd Chinese Patent Medicine Product Portfolio Table 142. Harbin Pharmaceutical Group Co., Ltd Recent Development Table 143. Guangzhou Pharmaceutical Group Co., Ltd. Company Information Table 144. Guangzhou Pharmaceutical Group Co., Ltd. Business Overview Table 145. Guangzhou Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 146. Guangzhou Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio Table 147. Guangzhou Pharmaceutical Group Co., Ltd. Recent Development Table 148. Northeast Pharmaceutical Group Co., Ltd. Company Information Table 149. Northeast Pharmaceutical Group Co., Ltd. Business Overview Table 150. Northeast Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 151. Northeast Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio Table 152. Northeast Pharmaceutical Group Co., Ltd. Recent Development Table 153. North America Chinese Patent Medicine Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 154. North America Chinese Patent Medicine Sales by Country (2021-2026) & (k tons) Table 155. North America Chinese Patent Medicine Sales Market Share by Country (2021-2026) Table 156. North America Chinese Patent Medicine Sales Forecast by Country (2027-2032) & (k tons) Table 157. North America Chinese Patent Medicine Sales Market Share Forecast by Country (2027-2032) Table 158. North America Chinese Patent Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. North America Chinese Patent Medicine Market Size by Country (2021-2026) & (US$ Million) Table 160. North America Chinese Patent Medicine Market Share by Country (2021-2026) Table 161. North America Chinese Patent Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. North America Chinese Patent Medicine Market Share Forecast by Country (2027-2032) Table 163. Europe Chinese Patent Medicine Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 164. Europe Chinese Patent Medicine Sales by Country (2021-2026) & (k tons) Table 165. Europe Chinese Patent Medicine Sales Market Share by Country (2021-2026) Table 166. Europe Chinese Patent Medicine Sales Forecast by Country (2027-2032) & (k tons) Table 167. Europe Chinese Patent Medicine Sales Market Share Forecast by Country (2027-2032) Table 168. Europe Chinese Patent Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Europe Chinese Patent Medicine Market Size by Country (2021-2026) & (US$ Million) Table 170. Europe Chinese Patent Medicine Market Share by Country (2021-2026) Table 171. Europe Chinese Patent Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Europe Chinese Patent Medicine Market Share Forecast by Country (2027-2032) Table 173. Asia-Pacific Chinese Patent Medicine Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 174. Asia-Pacific Chinese Patent Medicine Sales by Country (2021-2026) & (k tons) Table 175. Asia-Pacific Chinese Patent Medicine Sales Market Share by Country (2021-2026) Table 176. Asia-Pacific Chinese Patent Medicine Sales Forecast by Country (2027-2032) & (k tons) Table 177. Asia-Pacific Chinese Patent Medicine Sales Market Share Forecast by Country (2027-2032) Table 178. Asia-Pacific Chinese Patent Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Asia-Pacific Chinese Patent Medicine Market Size by Country (2021-2026) & (US$ Million) Table 180. Asia-Pacific Chinese Patent Medicine Market Share by Country (2021-2026) Table 181. Asia-Pacific Chinese Patent Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Asia-Pacific Chinese Patent Medicine Market Share Forecast by Country (2027-2032) Table 183. Latin America Chinese Patent Medicine Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 184. Latin America Chinese Patent Medicine Sales by Country (2021-2026) & (k tons) Table 185. Latin America Chinese Patent Medicine Sales Market Share by Country (2021-2026) Table 186. Latin America Chinese Patent Medicine Sales Forecast by Country (2027-2032) & (k tons) Table 187. Latin America Chinese Patent Medicine Sales Market Share Forecast by Country (2027-2032) Table 188. Latin America Chinese Patent Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 189. Latin America Chinese Patent Medicine Market Size by Country (2021-2026) & (US$ Million) Table 190. Latin America Chinese Patent Medicine Market Share by Country (2021-2026) Table 191. Latin America Chinese Patent Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 192. Latin America Chinese Patent Medicine Market Share Forecast by Country (2027-2032) Table 193. Middle East and Africa Chinese Patent Medicine Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 194. Middle East and Africa Chinese Patent Medicine Sales by Country (2021-2026) & (k tons) Table 195. Middle East and Africa Chinese Patent Medicine Sales Market Share by Country (2021-2026) Table 196. Middle East and Africa Chinese Patent Medicine Sales Forecast by Country (2027-2032) & (k tons) Table 197. Middle East and Africa Chinese Patent Medicine Sales Market Share Forecast by Country (2027-2032) Table 198. Middle East and Africa Chinese Patent Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 199. Middle East and Africa Chinese Patent Medicine Market Size by Country (2021-2026) & (US$ Million) Table 200. Middle East and Africa Chinese Patent Medicine Market Share by Country (2021-2026) Table 201. Middle East and Africa Chinese Patent Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 202. Middle East and Africa Chinese Patent Medicine Market Share Forecast by Country (2027-2032) Table 203. Key Raw Materials Table 204. Raw Materials Key Suppliers Table 205. Chinese Patent Medicine Distributors List Table 206. Chinese Patent Medicine Customers List Table 207. Research Programs/Design for This Report Table 208. Authors List of This Report Table 209. Secondary Sources Table 210. Primary Sources List of Figures Figure 1. Chinese Patent Medicine Image Figure 2. Global Chinese Patent Medicine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Chinese Patent Medicine Market Size (2021-2032) & (US$ Million) Figure 4. Global Chinese Patent Medicine Sales (2021-2032) & (k tons) Figure 5. Liquid Image Figure 6. Global Liquid Sales YoY Growth (2021-2032) & (k tons) Figure 7. Tablet Image Figure 8. Global Tablet Sales YoY Growth (2021-2032) & (k tons) Figure 9. Syrup Image Figure 10. Global Syrup Sales YoY Growth (2021-2032) & (k tons) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (k tons) Figure 13. Global Chinese Patent Medicine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Chinese Patent Medicine Market Share by Type 2025 VS 2032 Figure 15. North America Chinese Patent Medicine Sales Market Share in Volume by Type in 2025 Figure 16. North America Chinese Patent Medicine Sales Market Share in Value by Type in 2025 Figure 17. Europe Chinese Patent Medicine Sales Market Share in Volume by Type in 2025 Figure 18. Europe Chinese Patent Medicine Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Chinese Patent Medicine Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Chinese Patent Medicine Sales Market Share in Value by Type in 2025 Figure 21. Latin America Chinese Patent Medicine Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Chinese Patent Medicine Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Chinese Patent Medicine Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Chinese Patent Medicine Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Chinese Patent Medicine Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Online Sales Image Figure 28. Global Online Sales Sales YoY Growth (2021-2032) & (k tons) Figure 29. Offline Sales Image Figure 30. Global Offline Sales Sales YoY Growth (2021-2032) & (k tons) Figure 31. Global Chinese Patent Medicine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Chinese Patent Medicine Market Share by Application 2025 VS 2032 Figure 33. North America Chinese Patent Medicine Sales Market Share in Volume by Application in 2025 Figure 34. North America Chinese Patent Medicine Sales Market Share in Value by Application in 2025 Figure 35. Europe Chinese Patent Medicine Sales Market Share in Volume by Application in 2025 Figure 36. Europe Chinese Patent Medicine Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Chinese Patent Medicine Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Chinese Patent Medicine Sales Market Share in Value by Application in 2025 Figure 39. Latin America Chinese Patent Medicine Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Chinese Patent Medicine Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Chinese Patent Medicine Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Chinese Patent Medicine Sales Market Share in Value by Application in 2025 Figure 43. North America Chinese Patent Medicine Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 44. North America Chinese Patent Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Chinese Patent Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Chinese Patent Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Chinese Patent Medicine Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 48. Europe Chinese Patent Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Chinese Patent Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Chinese Patent Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Chinese Patent Medicine Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 52. Asia-Pacific Chinese Patent Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Chinese Patent Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Chinese Patent Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Chinese Patent Medicine Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 56. Latin America Chinese Patent Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Chinese Patent Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Chinese Patent Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Chinese Patent Medicine Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 60. Middle East and Africa Chinese Patent Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Chinese Patent Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Chinese Patent Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Chinese Patent Medicine Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Chinese Patent Medicine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Liquid
  • Tablet
  • Syrup
  • Others
Applications
  • Online Sales
  • Offline Sales
Companies covered
  • Chongqing Pharmaceutical Co., Ltd
  • China Pharmaceutical Group Corporation
  • Xinhualu Anti-Pharmaceutical Group Co., Ltd.
  • Tianjin Pharmaceutical Group Co., Ltd.
  • Taiji Group Co., Ltd.
  • Shijiazhuang Pharmaceutical Group Co., Ltd.
  • Shanghai Pharmaceutical (Group) Co., Ltd.
  • Nanjing Pharmaceutical Co., Ltd
  • Nanjing Pharmaceutical Industry (Group) Co., Ltd.
  • Jiangxi Pharmaceutical Group Corporation
  • Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd.
  • North China Pharmaceutical Group Co., Ltd.
  • Hangzhou Huadong Pharmaceutical Group Co., Ltd.
  • Harbin Pharmaceutical Group Co., Ltd
  • Guangzhou Pharmaceutical Group Co., Ltd.
  • Northeast Pharmaceutical Group Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Chinese Patent Medicine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Chinese Patent Medicine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Chinese Patent Medicine Market by Type
  6. 1.3.1 Liquid
  7. 1.3.2 Tablet
  8. 1.3.3 Syrup
  9. 1.3.4 Others
  10. 1.4 Global Chinese Patent Medicine Market Size by Type
  11. 1.4.1 Global Chinese Patent Medicine Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Chinese Patent Medicine Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Chinese Patent Medicine Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Chinese Patent Medicine Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Chinese Patent Medicine Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Chinese Patent Medicine Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Chinese Patent Medicine Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Chinese Patent Medicine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Chinese Patent Medicine Industry Trends
  2. 2.2 Chinese Patent Medicine Industry Drivers
  3. 2.3 Chinese Patent Medicine Industry Opportunities and Challenges
  4. 2.4 Chinese Patent Medicine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Chinese Patent Medicine Revenue (2021-2026)
  2. 3.2 Global Top Players by Chinese Patent Medicine Sales (2021-2026)
  3. 3.3 Global Top Players by Chinese Patent Medicine Price (2021-2026)
  4. 3.4 Global Chinese Patent Medicine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Chinese Patent Medicine Major Company Production Sites & Headquarters
  6. 3.6 Global Chinese Patent Medicine Company, Product Type & Application
  7. 3.7 Global Chinese Patent Medicine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Chinese Patent Medicine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Chinese Patent Medicine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Chinese Patent Medicine Tier 1, Tier 2, and Tier 3
4 Chinese Patent Medicine Regional Status and Outlook
  1. 4.1 Global Chinese Patent Medicine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Chinese Patent Medicine Historic Market Size by Region
  3. 4.2.1 Global Chinese Patent Medicine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Chinese Patent Medicine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Chinese Patent Medicine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Chinese Patent Medicine Forecasted Market Size by Region
  7. 4.3.1 Global Chinese Patent Medicine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Chinese Patent Medicine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Chinese Patent Medicine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Chinese Patent Medicine by Application
  1. 5.1 Chinese Patent Medicine Market by Application
  2. 5.1.1 Online Sales
  3. 5.1.2 Offline Sales
  4. 5.2 Global Chinese Patent Medicine Market Size by Application
  5. 5.2.1 Global Chinese Patent Medicine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Chinese Patent Medicine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Chinese Patent Medicine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Chinese Patent Medicine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Chinese Patent Medicine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Chinese Patent Medicine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Chinese Patent Medicine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Chinese Patent Medicine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Chongqing Pharmaceutical Co., Ltd
  2. 6.1.1 Chongqing Pharmaceutical Co., Ltd Company Information
  3. 6.1.2 Chongqing Pharmaceutical Co., Ltd Business Overview
  4. 6.1.3 Chongqing Pharmaceutical Co., Ltd Chinese Patent Medicine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Chongqing Pharmaceutical Co., Ltd Chinese Patent Medicine Product Portfolio
  6. 6.1.5 Chongqing Pharmaceutical Co., Ltd Recent Developments
  7. 6.2 China Pharmaceutical Group Corporation
  8. 6.2.1 China Pharmaceutical Group Corporation Company Information
  9. 6.2.2 China Pharmaceutical Group Corporation Business Overview
  10. 6.2.3 China Pharmaceutical Group Corporation Chinese Patent Medicine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 China Pharmaceutical Group Corporation Chinese Patent Medicine Product Portfolio
  12. 6.2.5 China Pharmaceutical Group Corporation Recent Developments
  13. 6.3 Xinhualu Anti-Pharmaceutical Group Co., Ltd.
  14. 6.3.1 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Company Information
  15. 6.3.2 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Business Overview
  16. 6.3.3 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio
  18. 6.3.5 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Recent Developments
  19. 6.4 Tianjin Pharmaceutical Group Co., Ltd.
  20. 6.4.1 Tianjin Pharmaceutical Group Co., Ltd. Company Information
  21. 6.4.2 Tianjin Pharmaceutical Group Co., Ltd. Business Overview
  22. 6.4.3 Tianjin Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Tianjin Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio
  24. 6.4.5 Tianjin Pharmaceutical Group Co., Ltd. Recent Developments
  25. 6.5 Taiji Group Co., Ltd.
  26. 6.5.1 Taiji Group Co., Ltd. Company Information
  27. 6.5.2 Taiji Group Co., Ltd. Business Overview
  28. 6.5.3 Taiji Group Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Taiji Group Co., Ltd. Chinese Patent Medicine Product Portfolio
  30. 6.5.5 Taiji Group Co., Ltd. Recent Developments
  31. 6.6 Shijiazhuang Pharmaceutical Group Co., Ltd.
  32. 6.6.1 Shijiazhuang Pharmaceutical Group Co., Ltd. Company Information
  33. 6.6.2 Shijiazhuang Pharmaceutical Group Co., Ltd. Business Overview
  34. 6.6.3 Shijiazhuang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Shijiazhuang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio
  36. 6.6.5 Shijiazhuang Pharmaceutical Group Co., Ltd. Recent Developments
  37. 6.7 Shanghai Pharmaceutical (Group) Co., Ltd.
  38. 6.7.1 Shanghai Pharmaceutical (Group) Co., Ltd. Company Information
  39. 6.7.2 Shanghai Pharmaceutical (Group) Co., Ltd. Business Overview
  40. 6.7.3 Shanghai Pharmaceutical (Group) Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Shanghai Pharmaceutical (Group) Co., Ltd. Chinese Patent Medicine Product Portfolio
  42. 6.7.5 Shanghai Pharmaceutical (Group) Co., Ltd. Recent Developments
  43. 6.8 Nanjing Pharmaceutical Co., Ltd
  44. 6.8.1 Nanjing Pharmaceutical Co., Ltd Company Information
  45. 6.8.2 Nanjing Pharmaceutical Co., Ltd Business Overview
  46. 6.8.3 Nanjing Pharmaceutical Co., Ltd Chinese Patent Medicine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Nanjing Pharmaceutical Co., Ltd Chinese Patent Medicine Product Portfolio
  48. 6.8.5 Nanjing Pharmaceutical Co., Ltd Recent Developments
  49. 6.9 Nanjing Pharmaceutical Industry (Group) Co., Ltd.
  50. 6.9.1 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Company Information
  51. 6.9.2 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Business Overview
  52. 6.9.3 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Chinese Patent Medicine Product Portfolio
  54. 6.9.5 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Recent Developments
  55. 6.10 Jiangxi Pharmaceutical Group Corporation
  56. 6.10.1 Jiangxi Pharmaceutical Group Corporation Company Information
  57. 6.10.2 Jiangxi Pharmaceutical Group Corporation Business Overview
  58. 6.10.3 Jiangxi Pharmaceutical Group Corporation Chinese Patent Medicine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Jiangxi Pharmaceutical Group Corporation Chinese Patent Medicine Product Portfolio
  60. 6.10.5 Jiangxi Pharmaceutical Group Corporation Recent Developments
  61. 6.11 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd.
  62. 6.11.1 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Company Information
  63. 6.11.2 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Business Overview
  64. 6.11.3 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio
  66. 6.11.5 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Recent Developments
  67. 6.12 North China Pharmaceutical Group Co., Ltd.
  68. 6.12.1 North China Pharmaceutical Group Co., Ltd. Company Information
  69. 6.12.2 North China Pharmaceutical Group Co., Ltd. Business Overview
  70. 6.12.3 North China Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 North China Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio
  72. 6.12.5 North China Pharmaceutical Group Co., Ltd. Recent Developments
  73. 6.13 Hangzhou Huadong Pharmaceutical Group Co., Ltd.
  74. 6.13.1 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Company Information
  75. 6.13.2 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Business Overview
  76. 6.13.3 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio
  78. 6.13.5 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Recent Developments
  79. 6.14 Harbin Pharmaceutical Group Co., Ltd
  80. 6.14.1 Harbin Pharmaceutical Group Co., Ltd Company Information
  81. 6.14.2 Harbin Pharmaceutical Group Co., Ltd Business Overview
  82. 6.14.3 Harbin Pharmaceutical Group Co., Ltd Chinese Patent Medicine Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Harbin Pharmaceutical Group Co., Ltd Chinese Patent Medicine Product Portfolio
  84. 6.14.5 Harbin Pharmaceutical Group Co., Ltd Recent Developments
  85. 6.15 Guangzhou Pharmaceutical Group Co., Ltd.
  86. 6.15.1 Guangzhou Pharmaceutical Group Co., Ltd. Company Information
  87. 6.15.2 Guangzhou Pharmaceutical Group Co., Ltd. Business Overview
  88. 6.15.3 Guangzhou Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Guangzhou Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio
  90. 6.15.5 Guangzhou Pharmaceutical Group Co., Ltd. Recent Developments
  91. 6.16 Northeast Pharmaceutical Group Co., Ltd.
  92. 6.16.1 Northeast Pharmaceutical Group Co., Ltd. Company Information
  93. 6.16.2 Northeast Pharmaceutical Group Co., Ltd. Business Overview
  94. 6.16.3 Northeast Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Northeast Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio
  96. 6.16.5 Northeast Pharmaceutical Group Co., Ltd. Recent Developments
7 North America by Country
  1. 7.1 North America Chinese Patent Medicine Sales by Country
  2. 7.1.1 North America Chinese Patent Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Chinese Patent Medicine Sales by Country (2021-2026)
  4. 7.1.3 North America Chinese Patent Medicine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Chinese Patent Medicine Market Size by Country
  6. 7.2.1 North America Chinese Patent Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Chinese Patent Medicine Market Size by Country (2021-2026)
  8. 7.2.3 North America Chinese Patent Medicine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Chinese Patent Medicine Sales by Country
  2. 8.1.1 Europe Chinese Patent Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Chinese Patent Medicine Sales by Country (2021-2026)
  4. 8.1.3 Europe Chinese Patent Medicine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Chinese Patent Medicine Market Size by Country
  6. 8.2.1 Europe Chinese Patent Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Chinese Patent Medicine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Chinese Patent Medicine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Chinese Patent Medicine Sales by Country
  2. 9.1.1 Asia-Pacific Chinese Patent Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Chinese Patent Medicine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Chinese Patent Medicine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Chinese Patent Medicine Market Size by Country
  6. 9.2.1 Asia-Pacific Chinese Patent Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Chinese Patent Medicine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Chinese Patent Medicine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Chinese Patent Medicine Sales by Country
  2. 10.1.1 South America Chinese Patent Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Chinese Patent Medicine Sales by Country (2021-2026)
  4. 10.1.3 South America Chinese Patent Medicine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Chinese Patent Medicine Market Size by Country
  6. 10.2.1 South America Chinese Patent Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Chinese Patent Medicine Market Size by Country (2021-2026)
  8. 10.2.3 South America Chinese Patent Medicine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Chinese Patent Medicine Sales by Country
  2. 11.1.1 Middle East and Africa Chinese Patent Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Chinese Patent Medicine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Chinese Patent Medicine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Chinese Patent Medicine Market Size by Country
  6. 11.2.1 Middle East and Africa Chinese Patent Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Chinese Patent Medicine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Chinese Patent Medicine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Chinese Patent Medicine Value Chain Analysis
  2. 12.1.1 Chinese Patent Medicine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Chinese Patent Medicine Production Mode & Process
  7. 12.2 Chinese Patent Medicine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Chinese Patent Medicine Distributors
  10. 12.2.3 Chinese Patent Medicine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst